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ABSTRACT
Objectives: Aortoseptal angulation (AoSA) can predict
provocable left ventricular outflow tract obstruction
(LVOTO) in patients with symptomatic hypertrophic
cardiomyopathy (HCM). Lack of a standardised
measurement technique in HCM without the need for
complex three-dimensional (3D) imaging limits its
usefulness in routine clinical practice. This study aimed to
validate a simple measurement of AoSA using 2D
echocardiography and cardiac MR (CMR) imaging as a
predictor of LVOTO.
Methods:We retrospectively assessed 160 patients with
non-obstructive HCM, referred for exercise stress
echocardiography. AoSAwas measured using resting 2D
echocardiography in all patients, and CMR in 29. Twenty-
five controls with normal echocardiograms were used for
comparison.
Results: Patients with HCM had a reduced AoSA
compared with controls (113°±12 vs 126°±6), p<0.0001.
Sixty (38%) patients had provocable LVOTO, with smaller
angles than non-obstructive patients (108°±12 vs
116°±12, p<0.0001). AoSA, degree of mitral valvular
regurgitation and incomplete systolic anterior motion
(SAM) were associated with peak left ventricular outflow
tract gradient (r=0.508, p<0.0001). An angle ≤100° had
27% sensitivity, 91% specificity and 59% positive
predictive value for predicting provocable LVOTO. When
combined with SAM, specificity was 99% and positive
predictive value 88%. Intraclass correlation coefficient of
AoSA measured by two observers was 0.901 (p<0.0001).
Bland-Altman analysis of echocardiographic AoSA showed
good agreement with the CMR-derived angle.
Conclusions: Measurement of AoSA using
echocardiography in HCM is easy, reproducible and
comparable to CMR. Patients with provocable LVOTO have
reduced angles compared with non-obstructive patients.
AoSA is highly specific for provocable LVOTO and should
prompt further evaluation in symptomatic patients without
resting obstruction.
INTRODUCTION
Hypertrophic cardiomyopathy (HCM) is the
commonest inherited cardiac disease with a
population prevalence of 1 in 500.1 Left ven-
tricular outﬂow tract obstruction (LVOTO)
caused by systolic anterior motion (SAM) of
the mitral valve leaﬂets is present in
one-third of patients at rest,2 and occurs in
up to two-thirds of symptomatic patients
KEY MESSAGES
What is already known about this subject?
▸ Transthoracic echocardiography can be used to
measure aortoseptal angulation. However, data
using this technique in patients with hyper-
trophic cardiomyopathy and its associated geo-
metric abnormalities are lacking. It has been
suggested, using three-dimensional (3D)
imaging techniques, that aortoseptal angulation
is an important determinant of left ventricular
outflow tract obstruction.
What does this study add?
▸ This study modified the echocardiographic tech-
nique, and validates a standardised method of
aortoseptal angulation measurement that can be
used in patients with hypertrophic cardiomyop-
athy without recourse to complex 3D imaging. It
also demonstrated that a reduced aortoseptal
angle is highly specific for provocable left ven-
tricular outflow tract obstruction and should
prompt further evaluation in symptomatic
patients without resting gradients.
How might this impact on clinical practice?
▸ We have demonstrated that our methodology for
aortoseptal angle quantification using standard
2D transthoracic echocardiography provides a
simple, quick, relatively inexpensive, robust
method, which provides additional information
that may be of clinical benefit to patients with
hypertrophic cardiomyopathy. We propose that
reduced aortoseptal angle be considered to
serve as a ‘red flag’ for the presence of provoc-
able left ventricular outflow tract obstruction and
prompt further specialist stress imaging.
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without resting obstruction during manoeuvres that
reduce preload and afterload or increase contractility.3
The mechanism of SAM varies between patients, but in
most individuals it represents a complex interaction
between altered left ventricular (LV) chamber shape,
mitral leaﬂet length and orientation of the mitral and
submitral apparatus.4–6 Recently, it has been suggested
that aortoseptal angulation is an important determinant
of LVOTO that can be used as a predictor of provocable
obstruction in symptomatic patients without resting left
ventricular outﬂow tract (LVOT) gradients.7 However,
the lack of a standardised method of measurement that
can be used in patients with HCM without recourse to
complex three-dimensional (3D) imaging techniques
limits the usefulness of this parameter in routine clinical
practice. Transthoracic echocardiography is widely avail-
able, and can be used to measure aortoseptal angula-
tion. However, data using this technique in patients with
HCM and its associated geometric abnormalities are
lacking. The aims of this study were to validate a simple
measurement of aortoseptal angulation using 2D echo-
cardiography and cardiac MR (CMR) imaging and to
determine its relation to provocable LVOTO in patients
with HCM.
METHODS
Patient cohort
This was a retrospective cohort study. The study popula-
tion comprised consecutive patients with non-obstructive
HCM referred for exercise stress echocardiography
between August 2004 and December 2008. All patients
fulﬁlled conventional diagnostic criteria for HCM and
had symptoms or signs consistent with provocable
obstruction. None of the patients had received interven-
tional gradient reduction therapy (myectomy or alcohol
ablation). Contemporaneous peak oxygen consumption
measured during symptom limited upright bicycle erg-
ometer exercise testing, functional class and medication
were recorded in all patients. The control group con-
sisted of 25 age-matched and sex-matched individuals
referred for transthoracic echocardiography to investi-
gate symptoms of chest pain or breathlessness, who were
subsequently found to have normal studies, with no
history of hypertension, myocardial or valvular heart
disease.
Transthoracic echocardiography
Resting transthoracic echocardiography was performed
using vivid i7 (General Electric Vingmed Ultrasound,
Horten, Norway) and Philips Sonos 7500 (Philips
Medical Systems, Andover, Massachusetts, USA) plat-
forms using standard acquisition protocols. Exercise
echocardiography was performed using the same equip-
ment during symptom-limited exercise on an upright
bicycle ergometer using a ramp protocol.
Echocardiographic parameters were measured accord-
ing to European Society of Echocardiography
guidelines,8–10 using EchoPAC (General Electric) soft-
ware. Basal interventricular septal thickness was mea-
sured in the parasternal short-axis view. SAM was
deﬁned as incomplete if there was any movement of the
mitral valve leaﬂets or chordae towards the ventricular
septal endocardium without septal contact and complete
when there was contact with the ventricular septum
during systole. Mitral regurgitation was graded visually as
none, mild, moderate or severe at rest and during provo-
cation.9 Maximal LVOT gradient was measured using
continuous wave Doppler in the apical ﬁve-chamber
view at rest, during and immediately after exercise. Care
was taken to exclude Doppler signals from mitral regur-
gitation and mid-cavity obstruction. Resting LVOTO was
deﬁned as a peak LVOT gradient ≥30 mm Hg, and pro-
vocable LVOTO was deﬁned as a gradient ≥50 mm Hg
during or immediately following exercise. The smallest
LVOT diameter below the aortic valve annulus during
ventricular systole was measured in the parasternal long-
axis view.
Measurement of aortoseptal angle
A parasternal long-axis view taken at the R wave of the
surface ECG was used for analysis. The image was ana-
lysed ofﬂine using a DICOM image viewer (SOBOX
V.2.3.0.1). The aortoseptal angle was measured using a
modiﬁcation of the technique originally described by
Fowles et al,11 and deﬁned as the angle between a line
drawn along the border of the right and left interventri-
cular septum (parallel to the proximal right ventricular
endocardial border), and a line drawn through the long
axis of the aortic root (ﬁgure 1), where a value of 180°
would be a straight line from septum to aorta and redu-
cing values represent increasing angulation.
Two cardiologists trained in echocardiography and
cardiomyopathy independently evaluated all images. In
29 patients, contemporaneous CMR images were avail-
able, and 3D data sets were loaded onto a standard
ofﬂine work station (Leonardo, Siemens Medical
Solutions) for analysis of the LV-aortic root angle. This
angle was measured in a multiplanar reformatted LVOT
view (intended to replicate the echocardiographic
images) using the same reference lines as for
echocardiography.
Statistics
Normally distributed variables are presented as mean
±SD, and non-normally distributed data as median and
IQR. Analysis was carried out using SPSS statistical soft-
ware V.19 (SPSS for Windows, IBM, USA). For all tests a
p value <0.05 was considered signiﬁcant. The mean
value of the angle measured by two observers was used
as an independent variable and assessed alongside the
above additional echocardiographic parameters using a
linear regression model to determine the univariate
associations of the peak provocable LVOT gradient.
Signiﬁcant factors were then entered into a stepwise
elimination model to determine multivariate predictors.
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A similar model was used to determine the associations
of the aortoseptal angle. Binary logistic regression and
receiver operator characteristic curve analysis was used
to determine the sensitivity and speciﬁcity of the aorto-
septal angle alone or in combination with resting incom-
plete SAM to detect the presence of provocable LVOTO.
Differences between two groups were assessed using
independent two-sample t test. One way Analysis of vari-
ance (ANOVA) with homogeneity of variance testing,
and post-hoc Bonferroni or Games-Howell corrections
were used as appropriate to assess differences between
multiple groups. Interobserver variability was assessed
using a two-way mixed model intraclass correlation coef-
ﬁcient (absolute type) and Pearson’s correlation.
Agreement between echocardiography and CMR mea-
sured angles was assessed using Pearson’s correlation
coefﬁcient and Bland-Altman analysis.
RESULTS
Patient characteristics
The initial study cohort comprised 179 patients. On the
day of exercise, 19 individuals were found to have a
LVOT gradient ≥30 mm Hg at rest and were excluded
from the analysis. The ﬁnal study cohort therefore con-
sisted of 160 patients (105 males, age 48±14 years).
Descriptive demographic and echocardiographic
characteristics are shown in table 1. Twelve (8%)
patients were unable to perform exercise and underwent
measurement of the LVOT gradient following the
administration of sublingual glyceryl trinitrate in com-
bination with Valsalva manoeuvre. Fifty-nine (37%)
patients were taking a β-blocker or calcium channel
antagonist as they were unable to discontinue before the
test for symptomatic reasons; a further 40 (25%) patients
withheld these drugs for a minimum of 48 h prior to
study. There was no difference in aortoseptal angle
between those who were either not on or withheld medi-
cation and those who took it on the day of exercise
(113°±12 vs 114°±12, p=0.709). In patients who were
unable to discontinue medication for symptomatic
reasons, there was a trend towards being more likely to
develop provocable obstruction (p=0.07). Twelve (20%)
patients with and 10 (10%) without provocable LVOTO
were in New York Heart Association (NYHA) class III
(p=0.097). There was no difference in provocable
LVOTO or aortoseptal angle (108°±12 vs 114°±12,
p=0.12) in those with or without hypertension, although
prevalence was low.
Aortoseptal angle
Patients with HCM had a smaller aortoseptal angle than
controls (113°±12 vs 126°±6, p<0.0001). There was no
difference in aortoseptal angle between men and
women (112°±13 vs 114°±11, p=0.297). There was a weak
negative correlation between aortoseptal angle and age
(r=−0.242, p=0.002) and also height (r=−0.181,
p=0.036). There was no relationship between aortoseptal
angle and body weight. There was no correlation
between aortoseptal angle and basal septal thickness or
LVOT systolic diameter.
Relationship between echocardiographic variables
and provocable LVOTO
Univariate analysis of echocardiographic variables and
their relationship to peak provocable LVOT gradient is
shown in table 2. Aortoseptal angle (β −1.18; CI −1.68
to −0.68; p<0.0001), incomplete SAM at rest (β 30.59; CI
18.15 to 43.04; p<0.0001) and degree of resting mitral
regurgitation (β 20.61; CI 2.64 to 38.59; p=0.025), overall
r=0.508, p<0.0001, were independently associated with
peak provocable LVOT gradient on multivariate analysis.
There was no difference in left ventricular end-diastolic
dimensions between patients with and without provoc-
able LVOTO.
The aortoseptal angle was smaller in patients with pro-
vocable LVOTO (108°±12 vs 116°±12, p<0.0001), ﬁgure 2.
Figure 1 Transthoracic echocardiogram, parasternal
long-axis view: example of construction of reference lines for
aortoseptal angle calculation. (A) The septal line was drawn
along the junction of left and right interventricular septum
(checked arrows), parallel to the proximal right endocardial
border (white arrows). (B) The aortoseptal angle was defined
as the angle between the septal line, and a line drawn
through the long axis of the aortic root where a value of 180°
would be a straight line from septum to aorta and reducing
values represent increasing angulation.
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When grouped by LVOT gradient, a smaller aortoseptal
angle was found in patients with increasingly severe
LVOTO, p=0.004, ﬁgure 3.
The area under receiver operator curves for aortosep-
tal angle, incomplete rest SAM, and the two parameters
combined for the prediction of provocable LVOTO were
Table 2 Univariate predictors of peak provocable LVOT gradient
CI
Factor r β Lower Upper p Value
Aortoseptal angle 0.319 −1.165 −1.708 −0.622 <0.0001
Basal septal thickness 0.048 −0.613 −2.618 1.392 0.547
Incomplete SAM (rest) 0.366 33.06 19.861 46.259 <0.0001
Mitral regurgitation grade (rest) 0.197 25.604 5.535 45.677 0.013
LVOT systolic diameter 0.014 −0.24 −2.949 2.469 0.861
LVOT, left ventricular outflow tract; SAM, systolic anterior motion.
Table 1 Patient demographics, clinical and echocardiographic characteristics
Demographics and baseline data
Age (years) 50 (19), range 16–82
Male gender 105 (66%)
Height (cm) 173 (14)
Weight (kg) 82±16
Peak oxygen consumption (mL/kg/min) 19.0 (11.4)
Per cent predicted peak oxygen consumption 67 (32)
Hypertension 14 (9%)
Medication
Calcium antagonist or β-blocker on day of test 59 (37%)
Calcium antagonist or β-blocker withheld >48 h pretest 40 (25%)
NYHA functional class
2 138 (86%)
3 22 (14%)
Echocardiographic parameters
Basal septal thickness (mm) 16±4
LVOT systolic diameter (mm) 19±3
Aortoseptal angle (degrees) 113±12 (range 79–140)
Left ventricular end diastolic diameter (mm) 46±6
Distribution of hypertrophy
Asymmetric 146 (91%)
Concentric 10 (6%)
Apical 4 (3%)
Rest Provocation
LVOT gradient (mm Hg)
Whole cohort 7 (6) 28 (69)
<30 160 (100%) 81 (51%)
30–49 – 19 (12%)
50–69 – 12 (8%)
≥70 – 48 (29%)
SAM
None 82 (51%) 62 (39%)
Incomplete 78 (49%) 39 (24%)
Complete 0 59 (37%)
Mitral regurgitation
None 19 (12%) 17 (11%)
Mild 139 (87%) 120 (75%)
Moderate 2 (1%) 20 (13%)
Severe 0 3 (2%)
Normally distributed data mean±SD, non-parametric data median (IQR).
LVOT, left ventricular outflow tract; NYHA, New York Heart Association; SAM, systolic anterior motion.
4 Critoph CH, Pantazis A, Tome Esteban MT, et al. Open Heart 2014;1:e000176. doi:10.1136/openhrt-2014-000176
Open Heart
group.bmj.com on January 29, 2015 - Published by http://openheart.bmj.com/Downloaded from 
0.68 (95% CI 0.59 to 0.76, p<0.0001), 0.67 (95% CI 0.58
to 0.76, p<0.0001 and 0.76 (95% CI 0.68 to 0.83,
p<0.0001), respectively (ﬁgure 4). Sensitivity, speciﬁcity
and positive predictive value for SAM and aortoseptal
angulation are shown in table 3.
Reproducibility
All images were deemed usable for the purpose of angle
measurement by both observers. The intraclass correlation
coefﬁcient of the aortoseptal angles measured by the two
observers was 0.90 (95% CI 0.87 to 0.93, p<0.0001), with
Pearson’s coefﬁcient r=0.82, p<0.0001. Correlation
between the aortoseptal angle measured using echocardi-
ography and CMR was r=0.50, p=0.006. The mean differ-
ence between the echocardiography angle−CMR angle
was −6° (SD 11). A Bland-Altman plot of the differences
in angle measured using the two modalities plotted
against their mean is shown in ﬁgure 5.
DISCUSSION
The main ﬁndings of this study are that patients with
HCM have a smaller aortoseptal angle than controls,
and individuals who develop provocable LVOTO during
exercise have a smaller angle than those without obstruc-
tion. The angle can be easily and reliably measured
using standard 2D transthoracic echocardiography in
patients with HCM, and is more speciﬁc than the pres-
ence of SAM for the identiﬁcation of provocable
LVOTO.
Determinants of provocable LVOTO and aortoseptal
angulation
A variety of structural features are associated with
LVOTO including anterior displacement of papillary
muscles,12 reduced LVOT area13 and primary mitral
valve abnormalities,14–16 but the essential component in
the majority of patients is contact between the mitral
valve and the interventricular septum caused by SAM of
Figure 3 Box plot showing decreasing aortoseptal angle
with increasing severity of provocable left ventricular outflow
tract (LVOT) gradient.
Figure 4 Receiver operator characteristic curves showing
the probability that aortoseptal angle, presence of systolic
anterior motion (SAM) of the mitral valve and both combined
predict patients who develop provocable left ventricular
outflow tract obstruction during exercise.
Figure 2 Histogram showing variation in aortoseptal angle
between patients with hypertrophic cardiomyopathy with and
without provocable left ventricular outflow tract obstruction
(LVOTO).
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the anterior, and, less commonly, the posterior leaﬂets.
Incomplete SAM at rest has long been recognised as a
clue to the presence of provocable LVOTO, but this
study demonstrates for the ﬁrst time that reduced aorto-
septal angle has a higher speciﬁcity when used as a
single measure. The relatively low sensitivity of both
parameters is expected given the high prevalence and
complexity of LVOTO, which is related to many add-
itional factors.
Variation in LVOT geometry is characteristic of HCM,
as well as of aortic valve disease and hypertension in
which a ‘sigmoid’ conﬁguration is common, particularly
with advancing age and reduction in LV cavity size.17–21
In adults, a smaller aortoseptal angle is associated with
increased aortic pressure wave reﬂection and higher
central blood pressure,22 although no causal relationship
has been demonstrated to date and in children a
smaller aortoseptal angle is a highly sensitive, speciﬁc
and positive predictive marker for the development of
subaortic stenosis,23 and can be used as an echocardio-
graphic feature to identify individuals at risk.24
Data on the importance of LVOT diameter in predict-
ing patients with provocable obstruction are conﬂicting
possibly due to differences in methodology.3 25 26 Owing
to the dynamic nature of provocable LVOTO, measure-
ment of this parameter may often be distal to the point
of SAM-septal contact and relatively ﬁxed, and therefore
may not accurately reﬂect 3D LVOT area. The lack of an
unequivocal association is not therefore surprising. We
measured the LVOT diameter using 2D images in the
parasternal long-axis view and found no inﬂuence on
the presence or magnitude of LVOT gradient.
Technique of aortoseptal angulation measurement
CMR and CT imaging provide a 3D measurement of
aortoseptal angulation, which has been shown to predict
LVOTO provoked using Valsalva or amyl nitrite inde-
pendent of basal septal thickness.7 A variety of methods
have been used for measurement of the aortoseptal
angle using 2D transthoracic echocardiography. The
most commonly adopted is the angle formed by the
long axis of the ascending aorta and the plane of the
ventricular septum, which has excellent interobserver
correlation.11 24 27 28 While 2D echocardiography has
been used multiple times to measure aortoseptal angula-
tion, it has not been evaluated in HCM. The left ven-
tricular endocardial border in HCM rarely forms a
straight line, particularly in patients with a basal septal
bulge. We recognised the difﬁculties of ﬁnding consist-
ent echocardiographic landmarks from which to accur-
ately quantify the aortoseptal angle from standard 2D
images in HCM, and so attempted to determine refer-
ence lines that would be most consistently applicable
across echocardiographic studies and between observers.
We therefore modiﬁed the method originally described
by Fowles et al.11 Instead of using a line bisecting the
septum at the level of the mitral valve leaﬂets and 2 cm
apically, we constructed one at the junction of the left
and right interventricular septum, parallel to the prox-
imal right endocardial border. We hypothesised that this
Table 3 Sensitivity, specificity and positive predictive value to predict provocable left ventricular outflow tract obstruction in
patients with hypertrophic cardiomyopathy using resting echocardiographic parameters
Sensitivity (%) Specificity (%)
Positive predictive
value (%)
Incomplete SAM rest 70 64 54
Aortoseptal angle ≤100°
N=25 (16%)
27 91 59
Aortoseptal angle ≤100° and incomplete SAM rest
N=8 (5%)
12 99 88
Aortoseptal angle ≤110°
N=37 (23%)
62 71 56
Aortoseptal angle ≤110° and incomplete SAM rest
N=19 (12%)
23 95 74
SAM, systolic anterior motion.
Figure 5 Bland-Altman plot of the differences between
aortoseptal angulation measured using transthoracic
echocardiography and cardiac MR (CMR) imaging. Solid line
represents mean, dashed line represents mean ±2 SDs.
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technique would be a more accurate representation of
the true septal orientation in HCM and more likely to ﬁt
a straight line. We believe the major determinant of the
angle in HCM to be abnormal septal orientation, with
less variability seen in the position of the aorta. The
quality of echocardiographic images varies between indi-
viduals, and in a minority of patients ﬁt to a straight line
can be challenging. However, the results of our interob-
server analysis support the reliability of our method
across a large number of studies, and comparison with
CMR data shows good agreement.
Clinical relevance and applicability
Patients with refractory symptoms and resting LVOTO
should be considered for myectomy,29 30 or alcohol
septal ablation.31–33 Provocable LVOTO is associated
with functional impairment and heart failure symp-
toms,34–36 and there is good evidence that invasive treat-
ments should be offered to these patients.37 38
Therefore a simple clinical tool that helps identify
patients at risk of developing provocable LVOTO would
be of beneﬁt.
We propose that reduced aortoseptal angle be consid-
ered to serve as a ‘red ﬂag’ for the presence of provoc-
able LVOTO. If suspected, it can be quickly and easily
quantiﬁed, and even in the absence of resting SAM on
2D echocardiography should prompt further evaluation
with stress echocardiography. Availability of expertise for
stress echocardiography in patients with HCM is vari-
able, although it can be performed safely,39 and as such
the relatively low sensitivity of aortoseptal angle measure-
ment demonstrated here is of less importance. However,
the high speciﬁcity is likely to identify patients who may
then beneﬁt from treatment. As used here, current
guidelines to diagnose provocable LVOTO recommend
use of either a treadmill or bicycle in combination with
Doppler echocardiography during and/or immediately
following exercise, as simple manoeuvres such as
Valsalva may underestimate the gradient.30
We have demonstrated that our methodology for aor-
toseptal angle quantiﬁcation using standard 2D trans-
thoracic echocardiography provides a simple, quick,
relatively inexpensive, robust method that is comparable
to MR and provides additional information that may be
of clinical beneﬁt to patients with HCM. Furthermore,
the results may be equally relevant in other patients with
reduced aortoseptal angle, for example, those with
hypertension, and the elderly. Further study in these
groups is warranted.
LIMITATIONS
This is a retrospective observational study on a consecu-
tive cohort of patients selected for stress echocardiog-
raphy from a specialist cardiomyopathy clinic. We did
not assess speciﬁc abnormalities of the mitral valve,
anterior displacement of the papillary muscles or LVOT
area. Only symptomatic patients were referred for stress
echocardiography, and so the relevance of aortoseptal
angulation in asymptomatic patients is unknown.
One-third of patients were unable to discontinue medi-
cation for symptomatic reasons; this reﬂects real-world
practice, but may have underestimated the prevalence
and magnitude of LVOTO.
Basal septal thickness was relatively modest in our
cohort. However, increase in this measurement is asso-
ciated with a reduction in aortoseptal angle.7 Inclusion
of patients with more prominent basal septal hyper-
trophy may therefore be expected to increase sensitivity
and speciﬁcity of aortoseptal angulation for the diagno-
sis of provocable LVOTO.
CONCLUSION
Measurement of aortoseptal angulation using transthor-
acic echocardiography in patients with HCM is easy,
reproducible, comparable to MRI, and can be calculated
using standard echocardiographic software. Patients with
HCM have smaller aortoseptal angles than those found
in controls, where they are associated with higher peak
LVOT gradient. A reduced aortoseptal angle is highly
speciﬁc for provocable LVOTO and should prompt
further evaluation in symptomatic patients without
resting obstruction.
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